Molecular basis of congenital hypopigmentary disorders in humans: A review

被引:84
作者
Boissy, RE
Nordlund, JJ
机构
[1] Department of Dermatology, University of Cincinnati, College of Medicine, Cincinnati
[2] Department of Dermatology, University of Cincinnati, College of Medicine, Cincinnati, OH 45267-0592
来源
PIGMENT CELL RESEARCH | 1997年 / 10卷 / 1-2期
关键词
melanocyte; melanogenesis; hypopigmentary disorders;
D O I
10.1111/j.1600-0749.1997.tb00461.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many specific gene products are sequentially made and utilized by the melanocyte as it emigrates from its embryonic origin, migrates into specific target sites, synthesizes melanin(s) within a specialized organelle, transfers pigment granules to neighboring cells, and responds to various exogenous cues. A mutation in many of the respective encoding genes can disrupt this process of melanogenesis and can result in hypopigmentary disorders. Following are examples highlighting this scenario. A subset of neural crest derived cells emigrate from the dorsal surface of the neural tube, become committed to the melanoblast lineage, and are targeted along the dorsal lateral pathway The specific transcription factors PAX3 and MITF (microphthalmia transcription factor) appear to play a regulatory role in early embryonic development of the pigment system and in associated diseases (the Waardenburg syndromes). During the subsequent development and commitment of the melanoblast, concomitant expression of the receptors for fibroblasts growth factor (FGFR2), endothelin-B (EDNRB), and steel factor (cKIT) also appears essential for the continued survival of migrating melanoblasts. Lack or dysfunction of these receptors result in Apert syndrome, Hirschsprung syndrome and piebaldism, respectively. Once the melanocyte resides in its target tissue, a plethora of melanocyte specific enzymes and structural proteins are coordinately expressed to form the melanosome and to convert tyrosine to melanin within it. Mutations in the genes encoding these proteins results in a family of congenital hypopigmentary diseases called oculocutaneous albinism (OCA). The tyrosinase gene family of proteins (tyrosinase, TRP1, and TRP2) regulate the type of eumelanin synthesized and mutations affecting them result in OCA1, OCA3, and slaty (in the murine system), respectively The P protein, with 12 transmembrane domains localized to the melanosome, has no assigned function as of yet but is responsible for OCA2 when dysfunctional. There are other genetically based syndromes, phenotypically resembling albinism, in which the synthesis of pigmented melanosomes, as well as specialized organelles of other cell types, is compromised. The Hermansky-Pudlak syndrome (HPS) and the Chediak-Higashi syndrome (CHS) are two such disorders. Eventually, the functional melanocyte must be maintained in the tissue throughout life. In some cases it is lost either normally or prematurely. White hair results in the absence of melanocytes repopulating the germinative hair follicle during subsequent anagen stages. Vitiligo, in contrast, results from the destruction and removal of the melanocyte in the epidermis and mucous membranes.
引用
收藏
页码:12 / 24
页数:13
相关论文
共 111 条
  • [71] Identification of the murine beige gene by YAC complementation and positional cloning
    Perou, CM
    Moore, KJ
    Nagle, DL
    Misumi, DJ
    Woolf, EA
    McGrail, SH
    Holmgren, L
    Brody, TH
    Dussault, BJ
    Monroe, CA
    Duyk, GM
    Pryor, RJ
    Li, LT
    Justice, MJ
    Kaplan, J
    [J]. NATURE GENETICS, 1996, 13 (03) : 303 - 308
  • [72] PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217
  • [73] A MISSENSE MUTATION OF THE ENDOTHELIN-B RECEPTOR GENE IN MULTIGENIC HIRSCHSPRUNGS-DISEASE
    PUFFENBERGER, EG
    HOSODA, K
    WASHINGTON, SS
    NAKAO, K
    DEWIT, D
    YANAGISAWA, M
    CHAKRAVARTI, A
    [J]. CELL, 1994, 79 (07) : 1257 - 1266
  • [74] RAMSAY M, 1992, AM J HUM GENET, V51, P879
  • [75] ASPIRIN, PROSTAGLANDIN-E1 AND QUIN-2 AM-INDUCED PLATELET DYSFUNCTION - RESTORATION OF FUNCTION BY NORADRENALIN
    RAO, GHR
    WHITE, JG
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1990, 39 (02): : 141 - 146
  • [76] A GENE FOR THE MOUSE PINK-EYED DILUTION LOCUS AND FOR HUMAN TYPE-II OCULOCUTANEOUS ALBINISM
    RINCHIK, EM
    BULTMAN, SJ
    HORSTHEMKE, B
    LEE, ST
    STRUNK, KM
    SPRITZ, RA
    AVIDANO, KM
    JONG, MTC
    NICHOLLS, RD
    [J]. NATURE, 1993, 361 (6407) : 72 - 76
  • [77] IDENTICAL MUTATIONS IN THE FGFR2 GENE CAUSE BOTH PFEIFFER AND CROUZON SYNDROME PHENOTYPES
    RUTLAND, P
    PULLEYN, LJ
    REARDON, W
    BARAITSER, M
    HAYWARD, R
    JONES, B
    MALCOLM, S
    WINTER, RM
    OLDRIDGE, M
    SLANEY, SF
    POOLE, MD
    WILKIE, AOM
    [J]. NATURE GENETICS, 1995, 9 (02) : 173 - 176
  • [78] DISTRIBUTION OF FGF-2 SUGGESTS IT HAS A ROLE IN CHICK LIMB BUD GROWTH
    SAVAGE, MP
    HART, CE
    RILEY, BB
    SASSE, J
    OLWIN, BB
    FALLON, JF
    [J]. DEVELOPMENTAL DYNAMICS, 1993, 198 (03) : 159 - 170
  • [79] MUTATIONS IN FGFRI AND FGFR2 CAUSE FAMILIAL AND SPORADIC PFEIFFER SYNDROME
    SCHELL, U
    HEHR, A
    FELDMAN, GJ
    ROBIN, NH
    ZACKAI, EH
    DEDIESMULDERS, C
    VISKOCHIL, DH
    STEWART, JM
    WOLFF, G
    OHASHI, H
    PRICE, RA
    COHEN, MM
    MUENKE, M
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (03) : 323 - 328
  • [80] OPHTHALMIC MANIFESTATIONS OF THE HERMANSKY-PUDLAK SYNDROME (OCULOCUTANEOUS ALBINISM AND HEMORRHAGIC DIATHESIS)
    SIMON, JW
    ADAMS, RJ
    CALHOUN, JH
    SHAPIRO, SS
    INGERMAN, CM
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 93 (01) : 71 - 77